223 studies were found. Here are studies 1 to 50.

1.		Suspended	506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia Conditions: recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
2.		No longer recruiting	506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ...
3.		Not yet recruiting	Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
4.		Recruiting	Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer
5.		Recruiting	Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ Conditions: breast cancer in situ; intraductal breast carcinoma
6.		Recruiting	Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
7.		Suspended	Arsenic Trioxide in Treating Men With Germ Cell Cancer Conditions: recurrent testicular cancer; extragonadal germ cell tumor
8.		Recruiting	Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma
9.		No longer recruiting	BMS-247550 in Treating Patients With Advanced Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
10.		No longer recruiting	BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
11.		Suspended	Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
12.		No longer recruiting	Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia Conditions: untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
13.		Recruiting	Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
14.		Not yet recruiting	Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer Conditions: recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
15.		Recruiting	Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer Condition: ovarian epithelial cancer
16.		Recruiting	Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer Conditions: peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
17.		Not yet recruiting	Celecoxib in Preventing Breast Cancer in Premenopausal Women Conditions: Breast Cancer; breast cancer in situ; lobular breast carcinoma in situ
18.		Recruiting	Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix Conditions: stage 0 cervical cancer; high-grade squamous intraepithelial lesion
19.		Recruiting	Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ...
20.		Recruiting	Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
21.		No longer recruiting	Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx Conditions: stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
22.		No longer recruiting	Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma; renal granular cell carcinoma
23.		No longer recruiting	Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Conditions: stage II colon cancer; stage III colon cancer
24.		No longer recruiting	Chemotherapy in Treating Patients with Stage II or Stage III Colon Cancer That Has Been Surgically Removed Conditions: stage III colon cancer; stage II colon cancer
25.		No longer recruiting	Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial Conditions: stage I breast cancer; stage II breast cancer; ductal breast carcinoma; cardiac toxicity
26.		No longer recruiting	Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
27.		Recruiting	Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Conditions: stage III melanoma; Recurrent Melanoma
28.		No longer recruiting	Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Conditions: stage III rectal cancer; adenocarcinoma of the rectum; stage II rectal cancer
29.		Recruiting	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus
30.		Completed	Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Conditions: Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; stage IIIA non-small cell lung cancer; ...
31.		Recruiting	Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma Conditions: stage III mantle cell lymphoma; stage IV mantle cell lymphoma; stage II mantle cell lymphoma
32.		Completed	Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer Conditions: ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
33.		No longer recruiting	Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer (Pancoast Tumors) Conditions: stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
34.		Recruiting	Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia Conditions: adult acute myeloid leukemia in remission; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
35.		No longer recruiting	Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer Conditions: transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer
36.		Recruiting	Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
37.		No longer recruiting	Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer
38.		No longer recruiting	Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Conditions: stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ...
39.		No longer recruiting	Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer Conditions: stage I breast cancer; stage II breast cancer
40.		Recruiting	Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Older Patients With Previously Untreated Non-Hodgkin's Lymphoma Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
41.		No longer recruiting	Combination Chemotherapy and Radiation Therapy In Treating Patients With Stage III or Stage IV Cancer of the Hypopharynx or Tongue Conditions: stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
42.		No longer recruiting	Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Conditions: stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
43.		No longer recruiting	Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung
44.		Recruiting	Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
45.		Recruiting	Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
46.		No longer recruiting	Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Conditions: recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
47.		Completed	Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
48.		Recruiting	Combination Chemotherapy in Treating Patients With Bladder Cancer Conditions: stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
49.		No longer recruiting	Combination Chemotherapy in Treating Patients With Breast Cancer Conditions: stage IIIA breast cancer; stage II breast cancer
50.		No longer recruiting	Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer